Journal of Medicinal Chemistry · 2017 · 34 citations · 38 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationEnzyme InhibitionLigand BindingLigand-based DesignMolecular DockingStructure-activity Relationship AnalysisBinding Mode OptimizationEnzyme Inhibitor DiscoveryHydrogen BondingHydrogen Bonding InteractionsInhibitor ClassificationInhibitor ScreeningPhysicochemical PropertiesTarget-ligand Interactions
Herein we describe the identification of 4-{[1,2,4]triazolo[1,5- a ]pyridin-5-yl}benzonitrile-based inhibitors of the hypoxia-inducible factor prolylhydroxylase domain-1 (PHD-1) enzyme. These inhibitors were shown to possess a novel binding mode by X-ray crystallography, in which the triazolo N1 atom coordinates in a hitherto unreported monodentate interaction with the active site Fe 2+ ion, while the benzonitrile group accepts a hydrogen-bonding interaction from the side chain residue of Asn315. Further optimization led to potent PHD-1 inhibitors with good physicochemical and pharmacokinetic properties.
38
A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF
Richard K. Bruick, Steven L. McKnight · Science · 2001 · 2.5K citations
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Peter Carmeliet, Yuval Dor, Jean-Marc Herbert et al. · Nature · 1998 · 2.5K citations
Gregg L. Semenza, G.L. Wang · Molecular and Cellular Biology · 1992 · 2.4K citations · Full text